Rigel Pharmaceuticals (RIGL) Short Interest Ratio & Short Volume → POTUS in ‘25 Not Biden/Trump, But (From The Freeport Society) (Ad) Free RIGL Stock Alerts $0.95 -0.03 (-3.06%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Rigel Pharmaceuticals Short Interest DataCurrent Short Volume5,670,000 sharesPrevious Short Volume5,170,000 sharesChange Vs. Previous Month+9.67%Dollar Volume Sold Short$5.95 millionShort Interest Ratio / Days to Cover3.8Last Record DateApril 30, 2024Outstanding Shares175,410,000 sharesPercentage of Shares Shorted3.23%Today's Trading Volume411,169 sharesAverage Trading Volume1,289,297 sharesToday's Volume Vs. Average32% Short Selling Rigel Pharmaceuticals ? Sign up to receive the latest short interest report for Rigel Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRIGL Short Interest Over TimeRIGL Days to Cover Over TimeRIGL Percentage of Float Shorted Over Time Ad The Freeport SocietyPOTUS in ‘25 Not Biden/Trump, ButAnd I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. Rigel Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20245,670,000 shares $5.95 million +9.7%N/A3.8 $1.05 4/15/20245,170,000 shares $5.95 million +3.2%N/A3.7 $1.15 3/31/20245,010,000 shares $7.41 million +1.4%N/A4 $1.48 3/15/20244,940,000 shares $6.72 million +32.1%N/A4.5 $1.36 2/29/20243,740,000 shares $5.68 million +6.9%N/A3.5 $1.52 2/15/20243,500,000 shares $4.27 million +2.3%N/A3.1 $1.22 Get the Latest News and Ratings for RIGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rigel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,420,000 shares $4.00 million No ChangeN/A3.3 $1.17 1/15/20243,420,000 shares $4.55 million -5.3%N/A2.8 $1.33 12/31/20233,610,000 shares $5.23 million -0.6%N/A3 $1.45 12/15/20233,630,000 shares $4.68 million -4.0%N/A3.1 $1.29 11/30/20233,780,000 shares $4.31 million -1.3%N/A3.2 $1.14 11/15/20233,830,000 shares $3.04 million +5.5%N/A4 $0.79 10/31/20233,630,000 shares $2.93 million -4.0%N/A3.5 $0.81 10/15/20233,780,000 shares $3.55 million +1.9%N/A3.3 $0.94 9/30/20233,710,000 shares $4.01 million +3.6%N/A3.7 $1.08 9/15/20233,580,000 shares $4.08 million -6.3%N/A3.1 $1.14 8/31/20233,820,000 shares $4.35 million +2.7%N/A3.1 $1.14 8/15/20233,720,000 shares $4.39 million -7.7%N/A2.5 $1.18 7/31/20234,030,000 shares $5.56 million +4.7%N/A2 $1.38 7/15/20233,850,000 shares $4.85 million +0.5%N/A1.8 $1.26 6/30/20233,830,000 shares $4.94 million -39.7%N/A1.8 $1.29 6/15/20236,350,000 shares $10.48 million -15.5%N/A2.8 $1.65 5/31/20237,510,000 shares $10.51 million -7.3%N/A2.9 $1.40 5/15/20238,100,000 shares $10.85 million -4.8%N/A2.6 $1.34 4/30/20238,510,000 shares $9.62 million +0.5%N/A3.2 $1.13 4/15/20238,470,000 shares $10.42 million +1.6%N/A2.9 $1.23 3/31/20238,340,000 shares $11.01 million -1.1%N/A2.7 $1.32 3/15/20238,430,000 shares $14.16 million +10.2%N/A2.6 $1.68 2/28/20237,650,000 shares $11.55 million +12.5%N/A2 $1.51 2/15/20236,800,000 shares $11.02 million +13.7%N/A1.6 $1.62 1/31/20235,980,000 shares $9.81 million +6.0%N/A1.5 $1.64 1/15/20235,640,000 shares $9.98 million +5.0%N/A1.5 $1.77 12/30/20225,370,000 shares $8.06 million -15.8%N/A1.4 $1.50 12/15/20226,380,000 shares $8.10 million +57.5%N/A1.8 $1.27 11/30/20224,050,000 shares $2.72 million -26.5%N/A1 $0.67 11/15/20225,510,000 shares $4.14 million -7.6%N/A2 $0.75 10/31/20225,960,000 shares $4.34 million -16.9%N/A1.9 $0.73 10/15/20227,170,000 shares $5.82 million -6.0%N/A2 $0.81 9/30/20227,630,000 shares $9.00 million -30.3%N/A2 $1.18 9/15/202210,950,000 shares $14.45 million +16.2%N/A2.6 $1.32The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. RIGL Short Interest - Frequently Asked Questions What is Rigel Pharmaceuticals' current short interest? Short interest is the volume of Rigel Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 5,670,000 shares of RIGL short. Learn More on Rigel Pharmaceuticals' current short interest. What is a good short interest ratio for Rigel Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RIGL shares currently have a short interest ratio of 4.0. Learn More on Rigel Pharmaceuticals's short interest ratio. Is Rigel Pharmaceuticals' short interest increasing or decreasing? Rigel Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 5,670,000 shares, an increase of 9.7% from the previous total of 5,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Rigel Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Rigel Pharmaceuticals: Regulus Therapeutics Inc. (7.33%), Merrimack Pharmaceuticals, Inc. (5.80%), G1 Therapeutics, Inc. (5.41%), Emergent BioSolutions Inc. (14.13%), Bolt Biotherapeutics, Inc. (8.80%), XOMA Co. (2.33%), Vanda Pharmaceuticals Inc. (4.17%), Verastem, Inc. (3.49%), Lexicon Pharmaceuticals, Inc. (9.52%), Gossamer Bio, Inc. (5.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Rigel Pharmaceuticals stock? Short selling RIGL is an investing strategy that aims to generate trading profit from Rigel Pharmaceuticals as its price is falling. RIGL shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rigel Pharmaceuticals? A short squeeze for Rigel Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RIGL, which in turn drives the price of the stock up even further. How often is Rigel Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RIGL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Regulus Therapeutics Short Interest Merrimack Pharmaceuticals Short Interest G1 Therapeutics Short Interest Emergent BioSolutions Short Interest Bolt Biotherapeutics Short Interest XOMA Short Interest Vanda Pharmaceuticals Short Interest Verastem Short Interest Lexicon Pharmaceuticals Short Interest Gossamer Bio Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RIGL) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace